Sector comparison
|
| United Therap... | Exact Science... | Insmed Inc. | Incyte Corpor... | Nasdaq 100 |
Overview
|
|
ISIN
|
| US91307C1027 | US30063P1057 | US4576693075 | US45337C1027 | US6311011026 |
Market Capitalization
|
|
13.28 bill. EUR | 7.68 bill. EUR | 12.89 bill. EUR | 10.99 bill. EUR | - |
Shares Outstanding
|
|
44.91 mill. | 185.76 mill. | 181 mill. | 193.52 mill. | - |
Dividend per Share*
|
|
- | - | - | - | - |
Dividend Yield
|
|
- | - | - | - | - |
P/E Ratio
|
|
12.21 | - | - | 387.56 | - |
P/E Ratio (with EPS Diluted)*
|
|
14.32 | -10.05 | -12.40 | 460.47 | - |
Free Float
|
|
- | - | - | 41.80% | - |
Performance
|
|
Exchange
|
| NASDAQ | NASDAQ | NASDAQ | NASDAQ | Indices Nasdaq |
1 Week
|
|
+6.08% | +0.47% | +5.52% | -8.90% | +2.25% |
1 Month
|
|
-13.38% | -8.38% | -4.41% | -12.99% | -10.61% |
3 Months
|
|
-9.68% | -25.16% | +11.10% | -8.20% | -6.59% |
YTD
|
|
-8.47% | -19.59% | +12.64% | -10.22% | -5.71% |
1 Year
|
|
+38.03% | -21.71% | +197.51% | +8.14% | +10.16% |
3 Years
|
|
+78.22% | -29.59% | +221.23% | -17.54% | +37.39% |
5 Years
|
|
+306.78% | +6.38% | +440.44% | -7.31% | +176.12% |
Fundamentals
|
| 2024 | 2024 | 2024 | 2024 | - |
Accounting Standard
|
| US GAAP | US GAAP | US GAAP | US GAAP | - |
Revenues
(in mill.)
|
|
2,877.4000 USD | 2,758.8670 USD | 363.7070 USD | 4,241.2170 USD | - |
Revenues Growth Rate
|
|
23.63% | 10.37% | 19.17% | 14.76% | - |
EBITDA
(in mill.)
|
|
- | - | - | - | - |
Operating Result
(in mill.)
|
|
1,377 USD | -1,048.7030 USD | -878.2520 USD | 61.3660 USD | - |
Income Before Taxes
(in mill.)
|
|
1,539 USD | -1,036.1610 USD | -910.0650 USD | 316.6300 USD | - |
Net Income
(in mill.)
|
|
1,195.1000 USD | -1,028.8570 USD | -913.7720 USD | 32.6150 USD | - |
Net Income Growth Rate
|
|
21.35% | 403.97% | 21.91% | -94.54% | - |
Earnings per Share
|
|
26.44 USD | -5.59 USD | -5.57 USD | 0.16 USD | - USD |
Total Equity
(in mill.)
|
|
6,444 USD | 2,402.2490 USD | 285.3790 USD | 3,447.6280 USD | - |
Equity Ratio
|
|
87.51% | 40.52% | 14.09% | 63.33% | - |
Return on Equity
|
|
18.55% | -42.83% | -320.20% | 0.95% | - |
Book Value per Share
|
|
143.48 USD | 12.93 USD | 1.58 USD | 17.82 USD | - |
Total Assets
(in mill.)
|
|
7,364 USD | 5,928.1390 USD | 2,025.2310 USD | 5,444.3220 USD | - |
Return on Assets
|
|
16.23% | -17.36% | -45.12% | 0.60% | - |
Operating Cash Flow
(in mill.)
|
|
1,327.1000 USD | 210.5360 USD | -683.8820 USD | 335.3370 USD | - |
* Latest financial year